Skip to content

TiO2-scaffolds for Alveolar Ridge Preservation

TiO2-scaffolds for Alveolar Ridge Preservation

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06269497
Acronym
TIOSCAFF
Enrollment
10
Registered
2024-02-21
Start date
2021-11-09
Completion date
2023-08-10
Last updated
2024-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alveolar Bone Resorption

Keywords

Scaffold, Bone resorption

Brief summary

The goal of this clinical trial is to evaluate the safety of placing TiO2 scaffolds in alveolar ridge and to evaluate if the scaffold material contributes to maintain the anatomy and the volume of the alveolar process after tooth extraction.

Detailed description

The primary objective of the clinical trial is to evaluate the safety of placing TiO2 scaffolds in alveolar ridge. The secondary objectives are; (1) to assess anatomical changes as measured by intraoral digital scanning at the time of extraction, after 6 months. (2) to evaluate soft tissue inflammation at 1, 2, 4, 12 and 24 weeks post-surgery, (3) to assess the preservation of the alveolar ridge following placement of TiO2 scaffold in the alveolae after tooth extraction, (4) to assess bone mineralization and quantitative healing in bone biopsies obtained at implant installation in the preserved site 6 months following treatment.

Interventions

PROCEDUREScaffold placement

The scaffold is placed in the alveola following extraction

RADIATIONCBCT

A Cone Beam Computer Tomography (CBCT) is taken of the area of interest after surgery

Sponsors

University of Oslo
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Intervention model description

Observational study / clinical trial

Eligibility

Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Subject must be ≥ 20 years, and present with a molar or premolar planned for extraction

Exclusion criteria

* Individuals with medical conditions that may affect soft tissue or bone metabolism * Previous local radiotherapy * Current use of chemotherapy * Systemic long-term corticosteroid treatment. * Diabetes * Smokers (\> 10 cigarettes/day). * Patients with active of untreated periodontal disease. * Present or past use of bisphosphonate treatment * Pregnant or nursing subjects * \> class 2 according to the ASA (American Society of Anesthesiologists) physical status classification * Acute infection or no apical periodontitis visible on radiograph of tooth planned for extraction.

Design outcomes

Primary

MeasureTime frameDescription
Adverse reactionsThrough study completion, an average of 1 yearEvaluate and register any adverse reactions following placement of the scaffold

Secondary

MeasureTime frameDescription
Anatomy6 months after surgeryEvaluate if the anatomy of the alveolar process is maintained or changed, analysis with use of cone-beam-computer-tomography showing the bone at the site immediately after surgery and 6 months after surgery. Any difference in bone volume will be recorded.
InflammationThrough study completion, an average of 1 yearEvaluate if any inflammatory response appeared in the surrounding tissues following placement of the scaffold according to the modified Landry index (Pippi 2017), The inflammation parameters are recorded with yes or no regarding presence.
MineralizationEvaluation of the histology, specimens tasken 6 months after surgery.Evaluate bone ingrowth and mineralization of the pores in the scaffold material by the use of micro-ct analysis, histology and immune histology

Countries

Norway

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 22, 2026